Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study - Full Text View - ClinicalTrials.gov

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study - Full Text View - ClinicalTrials.gov

This study is currently recruiting participants.

Verified February 2012 by University of Washington

First Received on February 28, 2012.   Last Updated on March 2, 2012   History of Changes

Official Title: Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study 

Sponsor:	University of Washington
Information provided by (Responsible Party):	Elizabeth Swisher, University of Washington
ClinicalTrials.gov Identifier:	NCT01544049

  Purpose

The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.

new open access journal section: Introducing the Nutrition & Metabolism section of Journal of Translational Medicine

Editorial

Introducing the Nutrition & Metabolism section of Journal of Translational Medicine

Laura Soldati, Elena Dogliotti, Irene Camera and Annalisa Terranegra

Journal of Translational Medicine 2012, 10:17 doi:10.1186/1479-5876-10-17
Published: 30 January 2012

Abstract (provisional)

Our food should be our medicine. Our medicine should be our food Hippocrates (460 BC - 377 BC) Nutrition experts, as well as specialists of different pathologies, are disclosing an ever increasing interest for protocols devoted to the welfare of patients and to prevention of nutrition related diseases.

open access: Evaluation of Genomic Applications in Practice and Prevention (EGAPP) (breast, ovarian, Lynch Syndrome...)

Evaluation of Genomic Applications in Practice and Prevention (EGAPP): Implementation and Evaluation of a Model Approach

The EGAPP initiative was launched by the CDC Office of Public Health Genomics in the fall of 2004. The initiative's goal is to establish and evaluate a systematic, evidence-based process for assessing genetic tests and other applications of genomic technology in transition from research to clinical and public health practice. EGAPP also aims to integrate:

• existing recommendations on implementation of genetic tests from professional organizations and advisory committees.^1,2,3,4
• knowledge and experience gained from existing processes for evaluation and appraisal (e.g., US Preventive Services Task Force, CDC’s Task Force on Community Preventive Services), previous CDC initiatives (e.g., the ACCE process for assembling and analyzing data on genetic tests; http://www.cdc.gov/genomics/gtesting/ACCE/FBR/index.htm) 5, and the international health technology assessment experience.

............................................................................

Working Group: Topics

Completed Topics | Topics Under Review | Topics Identified

RID: Preventing "C.diff" - Clostridium difficile

abstract: Hormone prevention strategies for breast, endometrial and ovarian cancers

"The prevention of epithelial ovarian cancer (EOC) is of particular interest given its high mortality rate and the lack of a cost-effective screening program. OC (oral contraceptives) usage significantly diminishes the incidence of EOC, in both the general population, as well as in patients with BRCA 1 or 2 mutations. Risk reduction is greatest with prolonged usage and persists for more than 30 years after OC use, but diminishes over time. Prospective, randomized trials, designed to control for all known variables, are mandatory to fully assess the potential for hormonal chemoprevention in breast, endometrial and ovarian cancers."

Research programs & studies - Cancer Prevention Institute of California

Research programs & studies
Studies of ovarian cancer

* Comorbidity and treatment for ovarian cancer / Survival following ovarian cancer

* Diet and risk of ovarian cancer

* Follow-up Care Us by Survivors (FOCUS study)

* Genetic epidemiology of ovarian cancer

Abstract Vitamin D: Panacea or a Pandora's box for prevention? CPR

"Among women, an increased rate of mortality was observed both for deficient concentrations and very high concentrations (>124nmol/L). Results suggest that caution should be exercised in using very high dose vitamin D supplementation in prevention trials that may result in high concentrations of vitamin D (>100nmol/L). Results suggest that caution should be exercised in using very high dose vitamin D supplementation in prevention trials that may result in high concentrations of vitamin D (>100nmol/L)."

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome

L-Glutamine Use in the Treatment and Prevention of Mucositis and Cachexia: A Naturopathic Perspective -- Noé 8 (4): 409 -- Integrative Cancer Therapies

Jan 5th, 2010 Q&A: Understanding and Managing Lynch Syndrome - Cancerwise | Cancer blog from M. D. Anderson Cancer Center

Basic overview

full free access: Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives

Small study but included view of patients and physician views.